Intensity of Humoral Immune Responses, Adverse Reactions, and Post-Vaccination Morbidity after Adenovirus Vector-Based and mRNA Anti-COVID-19 Vaccines

The aim of the study was to compare mRNA vaccine BNT162b2 with adenovirus vector- based vaccines in terms of presence of adverse reactions, immunogenicity, and protection against COVID-19. A total of 270 individuals were enrolled, of which 135 were vaccinated with adenovirus vector-based vaccines an...

Descripción completa

Detalles Bibliográficos
Autores principales: Voulgaridi, Ioanna, Sarrou, Styliani, Dadouli, Aikaterini, Peristeri, Athanasia-Marina, Nasika, Asimina, Onoufriadis, Ilias, Kyritsi, Maria A., Anagnostopoulos, Lemonia, Theodoridou, Aikaterini, Avakian, Ioanna, Pappa, Dimitra, Konstantinou, Adamos-Konstantinos, Papadamou, Georgia, Mouchtouri, Varvara A., Petinaki, Efi, Speletas, Matthaios, Hadjichristodoulou, Christos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416671/
https://www.ncbi.nlm.nih.gov/pubmed/36016156
http://dx.doi.org/10.3390/vaccines10081268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416671/
https://www.ncbi.nlm.nih.gov/pubmed/36016156
http://dx.doi.org/10.3390/vaccines10081268

Ejemplares similares